Skip to content

Efficacy and safety of acupuncture for chronic dizziness

Efficacy and safety of acupuncture for chronic dizziness: a randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN52695239
Enrollment
100
Registered
2013-06-25
Start date
2013-02-28
Completion date
Unknown
Last updated
2019-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic dizziness Signs and Symptoms Chronic dizziness

Interventions

The 80 chronic dizziness sufferers are randomly allocated to two different groups: 1. Treatment group: At least two acupuncture sessions per week for 4 weeks. 2. Contro

Sponsors

Beijing Municipal Health Bureau (China)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Current inclusion criteria as of 16/09/2013: 1. Vertigo of unknown cause 2. Dizziness of unknown cause 3. Meniere's disease 4. Psychogenic dizziness 5. Age 18 to 75 years, either sex Previous inclusion criteria: 1. Vertigo of unknown cause 2. Dizziness of unknown cause 3. Meniere's disease 4. Cervicogenic dizziness 6. Vestibular imbalance or disorder 8. Otologic disorder 9. Psychogenic dizziness 10. Age 18 to 75 years, either sex 11. Written and informed consent

Exclusion criteria

Exclusion criteria: 1. Labyrinthitis 2. Benign positional vertigo 3. Vestibular neuronitis 4. Duration of dizziness less than 2 months the past 2 years 5. Serious comorbid conditions (for example, life-threatening condition or progressive central disorder) 6. Patients who cannot communicate reliably with the investigator or who are not likely to cope with the requirements of the trial

Design outcomes

Primary

MeasureTime frame
1. Vertigo Symptom Scale (VSS) to assess the frequency of dizziness-related symptom; 2. Dizziness Handicap Inventory (DHI) to evaluate the functional, emotional and physical impact of dizziness on patients? daily life. The outcome measures above will be assessed at baseline (before treatment initiation), 4 weeks later of the first acupuncture, and 8 weeks later of the first acupuncture.

Secondary

MeasureTime frame
1. Short Form-36 quality-of-life questionnaire to evaluate a person?s health perception in daily life at baseline (before treatment initiation), 4 weeks later of the first acupuncture, and 8 weeks later of the first acupuncture. 2. Hospital Anxiety and Depression Scale to assess non-somatic symptoms of anxiety and depression at baseline (before treatment initiation), 4 weeks later of the first acupuncture, and 8 weeks later of the first acupuncture. 3. Perceived Credibility of acupuncture is evaluated by The Treatment Credibility Scale (TCS) after a 4-week acupuncture session. It is a 5-item questionnaire ranging from 1 (not at all) to 5 (very confident); items are averaged to provide a single treatment credibility score, with high scores reflecting high treatment credibility. 4. To evaluate the adequacy of blinding, we will ask participants to rate how certain they are that they have received traditional acupuncture or new method of acupuncture on a 7-point scale (1 very sure, 7 very uncertain) after 4 weeks of treatment. Participants will also report adverse events they experience, including discomfort or bruising at the sites of needle insertion, nausea, or feeling faint after each treatment.

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 10, 2026